PortfoliosLab logoPortfoliosLab logo
LIXT vs. PLTR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LIXT vs. PLTR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lixte Biotechnology Holdings, Inc. (LIXT) and Palantir Technologies Inc. (PLTR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LIXT achieves a 85.75% return, which is significantly higher than PLTR's -34.35% return.


LIXT

1D
-2.41%
1M
24.15%
YTD
85.75%
6M
78.48%
1Y
826.87%
3Y*
12.11%
5Y*
-24.32%
10Y*
-4.85%

PLTR

1D
-2.34%
1M
-14.74%
YTD
-34.35%
6M
-39.89%
1Y
-16.60%
3Y*
102.61%
5Y*
34.48%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

LIXT vs. PLTR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
LIXT
Lixte Biotechnology Holdings, Inc.
85.75%93.62%-13.63%-53.83%-57.23%-62.46%-54.84%
PLTR
Palantir Technologies Inc.
-34.35%135.03%340.48%167.45%-64.74%-22.68%135.50%

Correlation

The correlation between LIXT and PLTR is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.05

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Sep 30, 2020

0.13

Fundamentals

EPS

LIXT:

-$0.93

PLTR:

$0.89

Total Revenue (TTM)

LIXT:

$0.00

PLTR:

$5.22B

Gross Profit (TTM)

LIXT:

$0.00

PLTR:

$4.39B

EBITDA (TTM)

LIXT:

-$2.80M

PLTR:

$2.01B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LIXT vs. PLTR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LIXT
LIXT Risk / Return Rank: 9898
Overall Rank
LIXT Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
LIXT Sortino Ratio Rank: 9898
Sortino Ratio Rank
LIXT Omega Ratio Rank: 9696
Omega Ratio Rank
LIXT Calmar Ratio Rank: 9999
Calmar Ratio Rank
LIXT Martin Ratio Rank: 9797
Martin Ratio Rank

PLTR
PLTR Risk / Return Rank: 2929
Overall Rank
PLTR Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
PLTR Sortino Ratio Rank: 2929
Sortino Ratio Rank
PLTR Omega Ratio Rank: 2929
Omega Ratio Rank
PLTR Calmar Ratio Rank: 3030
Calmar Ratio Rank
PLTR Martin Ratio Rank: 2828
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LIXT vs. PLTR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lixte Biotechnology Holdings, Inc. (LIXT) and Palantir Technologies Inc. (PLTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LIXTPLTRDifference
Sharpe ratioReturn per unit of total volatility

+6.07

Sortino ratioReturn per unit of downside risk

+5.35

Omega ratioGain probability vs. loss probability

1.60

0.98

+0.62

Calmar ratioReturn relative to maximum drawdown

14.07

-0.38

+14.45

Martin ratioReturn relative to average drawdown

26.04

-0.75

+26.79

LIXT vs. PLTR - Sharpe Ratio Comparison

The current LIXT Sharpe Ratio is 5.74, which is higher than the PLTR Sharpe Ratio of -0.32. The chart below compares the historical Sharpe Ratios of LIXT and PLTR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LIXT vs. PLTR - Drawdown Comparison

The maximum LIXT drawdown since its inception was -99.12%, which is greater than PLTR's maximum drawdown of -84.62%. Use the drawdown chart below to compare losses from any high point for LIXT and PLTR.


Loading charts...

Drawdown Indicators


LIXTPLTRDifference

Max Drawdown

Largest peak-to-trough decline

-99.12%

-84.62%

-14.50%

Max Drawdown (1Y)

Largest decline over 1 year

-59.37%

-43.67%

-15.70%

Max Drawdown (3Y)

Largest decline over 3 years

-90.51%

-43.67%

-46.84%

Max Drawdown (5Y)

Largest decline over 5 years

-97.80%

-79.14%

-18.66%

Max Drawdown (10Y)

Largest decline over 10 years

-99.12%

Current Drawdown

Current decline from peak

-90.99%

-43.67%

-47.32%

Average Drawdown

Average peak-to-trough decline

-65.22%

-40.26%

-24.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

32.01%

22.06%

+9.95%

Volatility

LIXT vs. PLTR - Volatility Comparison

Lixte Biotechnology Holdings, Inc. (LIXT) has a higher volatility of 31.60% compared to Palantir Technologies Inc. (PLTR) at 19.16%. This indicates that LIXT's price experiences larger fluctuations and is considered to be riskier than PLTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LIXTPLTRDifference

Volatility (1M)

Calculated over the trailing 1-month period

31.60%

19.16%

+12.44%

Volatility (6M)

Calculated over the trailing 6-month period

69.39%

38.60%

+30.79%

Volatility (1Y)

Calculated over the trailing 1-year period

145.43%

51.49%

+93.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

136.15%

65.59%

+70.56%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

170.70%

69.73%

+100.97%

Dividends

LIXT vs. PLTR - Dividend Comparison

Neither LIXT nor PLTR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

LIXT vs. PLTR - Financials Comparison

This section allows you to compare key financial metrics between Lixte Biotechnology Holdings, Inc. and Palantir Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B202220232024202520260
1.63B
(LIXT) Total Revenue
(PLTR) Total Revenue
Values in USD except per share items

Frequently Asked Questions


LIXT and PLTR have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LIXT has higher volatility (31.60%) compared to PLTR (19.16%). In terms of maximum drawdown, LIXT dropped -99.12% vs PLTR's -84.62%.

LIXT currently has the higher Sharpe Ratio (5.74 vs -0.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LIXT and PLTR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer